Polish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Transpyloric Feeding in Severe Bronchopulmonary Dysplasia

Tylko zarejestrowani użytkownicy mogą tłumaczyć artykuły
Zaloguj się Zarejestruj się
Link zostanie zapisany w schowku
StatusZakończony
Sponsorzy
Children's Hospital of Philadelphia

Słowa kluczowe

Abstrakcyjny

Bronchopulmonary dysplasia (BPD) is the most common complication of extreme preterm birth. It impacts 10,000-15,000 infants in the US annually, including approximately 50% of infants with birth weight < 1000g. BPD is associated with multiple long-term adverse outcomes including chronic cardiopulmonary and neurodevelopmental impairments. Infants with severe BPD, defined as a need for ≥ 30% inspired oxygen and/or mechanical respiratory support at 36 weeks postmenstrual age (PMA), suffer the greatest burden of these chronic sequelae. Recurrent episodes of hypoxemia and prolonged exposure to supplemental oxygen are linked to the development of these impairments. Gastroesophageal reflux (GER) contributes to these mechanisms by exacerbating pulmonary inflammation and inducing bronchospasm. Unfortunately, clinically available methods to diagnose GER in infants are unreliable. Moreover, acid suppressive agents are both ineffective and carry high risk of serious life-threatening morbidity. Simple transpyloric feeding has promise, but has not been evaluated in BPD.
This study will pilot N-of-1 trials to assess whether transpyloric feeds reduce airway complications of GER and and whether this methodology can aid in identifying individual infants with severe BPD who are likely to benefit from prolonged use of transpyloric feeds.
Aim 1. To determine for each enrolled infant with severe BPD whether transpyloric compared to gastric feeds reduce the number of daily intermittent hypoxemic events (primary outcome) and improve a validated BPD severity score (secondary outcome).
The investigators hypothesize that 80% percent of enrolled infants will have significantly fewer daily intermittent hypoxemic events with transpyloric compared to gastric feeds and will have this feeding method formally recommended.
Aim 2. To pool results from multiple N-of-1 trials to determine whether transpyloric compared to gastric feeds reduce airway complications of GER in infants with severe BPD.
The investigators hypothesize that transpyloric compared to gastric feeds will be associated overall with a 15% reduction in number of daily intermittent hypoxemic events.

Daktyle

Ostatnia weryfikacja: 01/31/2018
Pierwsze przesłane: 05/14/2014
Szacowana liczba przesłanych rejestracji: 05/15/2014
Wysłany pierwszy: 05/19/2014
Ostatnia aktualizacja przesłana: 02/01/2018
Ostatnia opublikowana aktualizacja: 02/04/2018
Rzeczywista data rozpoczęcia badania: 12/17/2014
Szacowana data zakończenia podstawowej działalności: 07/14/2016
Szacowana data zakończenia badania: 07/14/2016

Stan lub choroba

Bronchopulmonary Dysplasia

Interwencja / leczenie

Other: transpyloric tube feeds

Other: gastric tube feeds

Faza

-

Grupy ramion

RamięInterwencja / leczenie
Active Comparator: transpyloric tube feeds
Continuous transpyloric tube feeds administered through an oral/nasal feeding tube.
Other: transpyloric tube feeds
Active Comparator: gastric tube feeds
Continuous gastric tube feeds administered through an oral/nasal feeding tube.
Other: gastric tube feeds

Kryteria kwalifikacji

Płeć kwalifikująca się do naukiAll
Przyjmuje zdrowych wolontariuszytak
Kryteria

Inclusion Criteria:

- Gestational age ≤ 32 weeks

- Severe BPD (FiO2 ≥ 30% and/or mechanical ventilation or non-invasive positive pressure respiratory support at the time of enrollment)

- Post menstrual age of 36-45 6/7 weeks at enrollment

- Parent and/or guardian permission (informed consent)

Exclusion Criteria:

- Prior intolerance to transpyloric feeds

- History of surgical anti-reflux procedure

- Congenital heart disease (not including patent ductus arterioles and hemodynamically insignificant ventricular septal defect or atrial septal defect)

- Structural abnormalities of the upper airway, lungs, or chest wall

- Other congenital malformations or syndromes that adversely affect life expectancy or cardio-pulmonary development

- Parent, guardian, or subject who, in the opinion of the investigators, are unlikely to participate for the duration of the study

Wynik

Podstawowe miary wyników

1. Change in transient intermittent hypoxemic events every 4 days [4 days]

transient hypoxemic events is defined for the purposes of this study as an oxygen saturation < 80% for ≥ 10 seconds and < 3 minutes recorded by continuous pulse oximetry.

Dołącz do naszej strony
na Facebooku

Najbardziej kompletna baza danych ziół leczniczych poparta naukowo

  • Działa w 55 językach
  • Ziołowe leki poparte nauką
  • Rozpoznawanie ziół na podstawie obrazu
  • Interaktywna mapa GPS - oznacz zioła na miejscu (wkrótce)
  • Przeczytaj publikacje naukowe związane z Twoim wyszukiwaniem
  • Szukaj ziół leczniczych po ich działaniu
  • Uporządkuj swoje zainteresowania i bądź na bieżąco z nowościami, badaniami klinicznymi i patentami

Wpisz objaw lub chorobę i przeczytaj o ziołach, które mogą pomóc, wpisz zioło i zobacz choroby i objawy, na które są stosowane.
* Wszystkie informacje oparte są na opublikowanych badaniach naukowych

Google Play badgeApp Store badge